Impact of vaccination on COVID-19 severity during the second wave in Brunei Darussalam, 2021.

IF 1 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Western Pacific Surveillance and Response Pub Date : 2024-03-25 eCollection Date: 2024-01-01 DOI:10.5365/wpsar.2024.15.1.992
Chee Fui Chong, Muhd Syafiq Abdullah, Pui Lin Chong, Rosmonaliza Asli, Babu Ivan Mani, Natalie Raimiza Momin, Justin Wong, Noor Affizan Rahman, Jackson Tan, Vui Heng Chong
{"title":"Impact of vaccination on COVID-19 severity during the second wave in Brunei Darussalam, 2021.","authors":"Chee Fui Chong, Muhd Syafiq Abdullah, Pui Lin Chong, Rosmonaliza Asli, Babu Ivan Mani, Natalie Raimiza Momin, Justin Wong, Noor Affizan Rahman, Jackson Tan, Vui Heng Chong","doi":"10.5365/wpsar.2024.15.1.992","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Coronavirus disease (COVID-19) vaccinations have been shown to prevent infection with efficacies ranging from 50% to 95%. This study assesses the impact of vaccination on the clinical severity of COVID-19 during the second wave in Brunei Darussalam in 2021, which was due to the Delta variant.</p><p><strong>Methods: </strong>Patients included in this study were randomly selected from those who were admitted with COVID-19 to the National Isolation Centre between 7 August and 6 October 2021. Cases were categorized as asymptomatic, mild (symptomatic without pneumonia), moderate (pneumonia), severe (needing supplemental oxygen therapy) or critical (needing mechanical ventilation) but for statistical analysis purposes were dichotomized into asymptomatic/mild or moderate/severe/critical cases. Univariate and multivariable analyses were conducted to identify risk factors associated with moderate/severe/critical disease. Propensity score-matched analysis was also performed to evaluate the impact of vaccination on disease severity.</p><p><strong>Results: </strong>The study cohort of 788 cases (mean age: 42.1 ± 14.6 years; 400 males) comprised 471 (59.8%) asymptomatic/mild and 317 (40.2%) moderate/severe/critical cases. Multivariable logistic regression analysis showed older age group (≥ 45 years), diabetes mellitus, overweight/obesity and vaccination status to be associated with increased severity of disease. In propensity score-matched analysis, the relative risk of developing moderate/severe/critical COVID-19 for fully vaccinated (two doses) and partially vaccinated (one dose) cases was 0.33 (95% confidence interval [CI]: 0.16-0.69) and 0.62 (95% CI: 0.46-0.82), respectively, compared with a control group of non-vaccinated cases. The corresponding relative risk reduction (RRR) values were 66.5% and 38.4%, respectively. Vaccination was also protective against moderate/severe/critical disease in a subgroup of overweight/obese patients (RRR: 37.2%, <i>P</i> = 0.007).</p><p><strong>Discussion: </strong>Among those who contracted COVID-19, older age, having diabetes, being overweight/obese and being unvaccinated were significant risk factors for moderate/severe/critical disease. Vaccination, even partial, was protective against moderate/severe/critical disease.</p>","PeriodicalId":31512,"journal":{"name":"Western Pacific Surveillance and Response","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10987314/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Western Pacific Surveillance and Response","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5365/wpsar.2024.15.1.992","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Coronavirus disease (COVID-19) vaccinations have been shown to prevent infection with efficacies ranging from 50% to 95%. This study assesses the impact of vaccination on the clinical severity of COVID-19 during the second wave in Brunei Darussalam in 2021, which was due to the Delta variant.

Methods: Patients included in this study were randomly selected from those who were admitted with COVID-19 to the National Isolation Centre between 7 August and 6 October 2021. Cases were categorized as asymptomatic, mild (symptomatic without pneumonia), moderate (pneumonia), severe (needing supplemental oxygen therapy) or critical (needing mechanical ventilation) but for statistical analysis purposes were dichotomized into asymptomatic/mild or moderate/severe/critical cases. Univariate and multivariable analyses were conducted to identify risk factors associated with moderate/severe/critical disease. Propensity score-matched analysis was also performed to evaluate the impact of vaccination on disease severity.

Results: The study cohort of 788 cases (mean age: 42.1 ± 14.6 years; 400 males) comprised 471 (59.8%) asymptomatic/mild and 317 (40.2%) moderate/severe/critical cases. Multivariable logistic regression analysis showed older age group (≥ 45 years), diabetes mellitus, overweight/obesity and vaccination status to be associated with increased severity of disease. In propensity score-matched analysis, the relative risk of developing moderate/severe/critical COVID-19 for fully vaccinated (two doses) and partially vaccinated (one dose) cases was 0.33 (95% confidence interval [CI]: 0.16-0.69) and 0.62 (95% CI: 0.46-0.82), respectively, compared with a control group of non-vaccinated cases. The corresponding relative risk reduction (RRR) values were 66.5% and 38.4%, respectively. Vaccination was also protective against moderate/severe/critical disease in a subgroup of overweight/obese patients (RRR: 37.2%, P = 0.007).

Discussion: Among those who contracted COVID-19, older age, having diabetes, being overweight/obese and being unvaccinated were significant risk factors for moderate/severe/critical disease. Vaccination, even partial, was protective against moderate/severe/critical disease.

2021 年文莱达鲁萨兰国第二波疫苗接种对 COVID-19 严重程度的影响。
目的:接种冠状病毒病(COVID-19)疫苗可预防感染,有效率在50%至95%之间。本研究评估了接种疫苗对 2021 年文莱达鲁萨兰国第二波 COVID-19 临床严重程度的影响:本研究中的患者是从2021年8月7日至10月6日期间国家隔离中心收治的COVID-19患者中随机抽取的。病例分为无症状、轻度(无症状但无肺炎)、中度(肺炎)、重度(需要补充氧气治疗)或危重(需要机械通气),但为了便于统计分析,将其分为无症状/轻度或中度/重度/危重病例。进行了单变量和多变量分析,以确定与中度/重度/危重症相关的风险因素。此外,还进行了倾向得分匹配分析,以评估接种疫苗对疾病严重程度的影响:研究队列中共有 788 例病例(平均年龄:42.1 ± 14.6 岁;男性 400 例),其中无症状/轻度病例 471 例(59.8%),中度/重度/危重病例 317 例(40.2%)。多变量逻辑回归分析显示,年龄较大(≥ 45 岁)、糖尿病、超重/肥胖和疫苗接种情况与疾病严重程度的增加有关。在倾向得分匹配分析中,与未接种疫苗的对照组相比,完全接种(两剂)和部分接种(一剂)的病例患中度/重度/危重COVID-19的相对风险分别为0.33(95%置信区间[CI]:0.16-0.69)和0.62(95%置信区间:0.46-0.82)。相应的相对风险降低率 (RRR) 值分别为 66.5% 和 38.4%。在超重/肥胖患者亚组中,接种疫苗对中度/重度/危重症也有保护作用(RRR:37.2%,P = 0.007):讨论:在感染COVID-19的患者中,年龄较大、患有糖尿病、超重/肥胖和未接种疫苗是导致中度/重度/危重症的重要风险因素。接种疫苗(即使是部分接种)对中度/重度/危重症有保护作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Western Pacific Surveillance and Response
Western Pacific Surveillance and Response PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
1.70
自引率
0.00%
发文量
23
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信